small is GMP approved for highly potent APIs

With 14 R&D and 3 GMP CESS® lines capable of handling highly potent compounds, Nanoform can meet your material needs at up to the multi ton-per-year scale

In 2019, Nanoform invested in its first cleanroom and GMP-compliant production line, then significantly increased its GMP manufacturing capacity by adding two new facilities in 2025.

Nanoform can handle most APIs with containment to 0.03 µg/m3 and scale manufacturing up to multiple tons per year using a single GMP line, enough to satisfy demand for the overwhelming majority of innovative APIs.

Recipe control via automation is built in providing product quality benefits via controls of critical processing parameters with accurate and repeatable performance and consistent quality. GMP suites are equipped with clean-in-place (CIP) and wash-in-place (WIP) capabilities, enabling faster and more efficient changeovers between campaigns. Ongoing automation projects will streamline manufacturing work still further enabling automated batch report generation. With predefined formulation and process controls, production is automated throughout, from loading raw materials to harvesting nanoparticles.